Iron is a modifier of the phenotypes of JAK2-mutant myeloproliferative neoplasms

By sjmartinez • February 10, 2023

Stetka J, Usart M, Kubovcakova L, Rai S, Nageswara Rao T, Sutter J, Hao-Shen H, Dirnhofer S, Geier F, Bader MS, Passweg JR, Manolova V, Dürrenberger F, Ahmed N, Schroeder T, Ganz T, Nemeth E, Silvestri L, Nai A, Camaschella C, Skoda RC. Iron is a modifier of the phenotypes of JAK2-mutant myeloproliferative neoplasms. Blood. 2023 Feb 9:blood.2022017976. doi: 10.1182/blood.2022017976. Epub ahead of print. PMID: 36758212.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine

Longitudinal validation of the PROMIS-16 in a sample of adults in the United States with back pain

Rodriguez A, Zeng C, Hays RD, Herman PM, Edelen MO. Longitudinal validation of the PROMIS-16 in a sample of adults in the United States with[...]

Diabetic Cardiomyopathy: What Clinicians Should Know

Smati H, Qadeer YK, Rodriguez M, Moras E, Fonarow GC, Isaacs SD, Marwick TH, Krittanawong C. Diabetic Cardiomyopathy: What Clinicians Should Know. Am J Med.[...]

Heart Failure With Preserved Ejection Fraction-A Role for Invasive Hemodynamics

Fonarow GC, Udelson JE, Yancy CW. Heart Failure With Preserved Ejection Fraction-A Role for Invasive Hemodynamics. JAMA Cardiol. 2024 Nov 6. doi: 10.1001/jamacardio.2024.3764. Epub ahead[...]